Style | Citing Format |
---|---|
MLA | Moosavi MS, Elham Y. "Aquaporins 1, 3 and 5 in Different Tumors, Their Expression, Prognosis Value and Role As New Therapeutic Targets." Pathology and Oncology Research, vol. 26, no. 2, 2020, pp. 615-625. |
APA | Moosavi MS, Elham Y (2020). Aquaporins 1, 3 and 5 in Different Tumors, Their Expression, Prognosis Value and Role As New Therapeutic Targets. Pathology and Oncology Research, 26(2), 615-625. |
Chicago | Moosavi MS, Elham Y. "Aquaporins 1, 3 and 5 in Different Tumors, Their Expression, Prognosis Value and Role As New Therapeutic Targets." Pathology and Oncology Research 26, no. 2 (2020): 615-625. |
Harvard | Moosavi MS, Elham Y (2020) 'Aquaporins 1, 3 and 5 in Different Tumors, Their Expression, Prognosis Value and Role As New Therapeutic Targets', Pathology and Oncology Research, 26(2), pp. 615-625. |
Vancouver | Moosavi MS, Elham Y. Aquaporins 1, 3 and 5 in Different Tumors, Their Expression, Prognosis Value and Role As New Therapeutic Targets. Pathology and Oncology Research. 2020;26(2):615-625. |
BibTex | @article{ author = {Moosavi MS and Elham Y}, title = {Aquaporins 1, 3 and 5 in Different Tumors, Their Expression, Prognosis Value and Role As New Therapeutic Targets}, journal = {Pathology and Oncology Research}, volume = {26}, number = {2}, pages = {615-625}, year = {2020} } |
RIS | TY - JOUR AU - Moosavi MS AU - Elham Y TI - Aquaporins 1, 3 and 5 in Different Tumors, Their Expression, Prognosis Value and Role As New Therapeutic Targets JO - Pathology and Oncology Research VL - 26 IS - 2 SP - 615 EP - 625 PY - 2020 ER - |